DAE HWA Pharmaceutical Co. Ltd Cash Flow Conversion Efficiency
DAE HWA Pharmaceutical Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, DAE HWA Pharmaceutical Co. Ltd (067080) has a cash flow conversion efficiency ratio of -0.020x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.72 Billion ≈ $-1.16 Million USD) by net assets (₩85.72 Billion ≈ $58.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of DAE HWA Pharmaceutical Co. Ltd (2011–2025)
Cash flow conversion efficiency of DAE HWA Pharmaceutical Co. Ltd from 2011 to 2025. This chart illustrates how DAE HWA Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View DAE HWA Pharmaceutical Co. Ltd stock quote for real-time trading data and today's change.
DAE HWA Pharmaceutical Co. Ltd Cash Flow Conversion Ratio Explained
DAE HWA Pharmaceutical Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
DAE HWA Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DAE HWA Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency. Also see DAE HWA Pharmaceutical Co. Ltd market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Consórcio Alfa de Administração S.A
SA:BRGE3
|
0.031x |
|
Multicampus Corporation
KQ:067280
|
0.001x |
|
Riverview Bancorp Inc
NASDAQ:RVSB
|
-0.024x |
|
Borosil Scientific
NSE:BOROSCI
|
0.018x |
|
IRM ENERGY LTD
NSE:IRMENERGY
|
0.083x |
|
Mangata Holding S.A.
WAR:MGT
|
-0.005x |
|
WTK Holdings Bhd
KLSE:4243
|
0.074x |
|
ANJI Technology Co. Ltd
TW:6477
|
0.059x |
Annual Cash Flow Conversion Efficiency for DAE HWA Pharmaceutical Co. Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of DAE HWA Pharmaceutical Co. Ltd from 2011 to 2025. Review how much free cash does DAE HWA Pharmaceutical Co. Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩79.14 Billion ≈ $53.63 Million |
₩5.43 Billion ≈ $3.68 Million |
0.069x | -19.40% |
| 2024-12-31 | ₩72.00 Billion ≈ $48.79 Million |
₩6.13 Billion ≈ $4.15 Million |
0.085x | +1155.66% |
| 2023-12-31 | ₩73.23 Billion ≈ $49.63 Million |
₩-590.27 Million ≈ $-400.02K |
-0.008x | -107.81% |
| 2022-12-31 | ₩77.99 Billion ≈ $52.85 Million |
₩8.05 Billion ≈ $5.45 Million |
0.103x | -21.32% |
| 2021-12-31 | ₩79.67 Billion ≈ $53.99 Million |
₩10.45 Billion ≈ $7.08 Million |
0.131x | +270.58% |
| 2020-12-31 | ₩81.98 Billion ≈ $55.56 Million |
₩2.90 Billion ≈ $1.97 Million |
0.035x | +6935.37% |
| 2019-12-31 | ₩79.35 Billion ≈ $53.77 Million |
₩-41.07 Million ≈ $-27.83K |
-0.001x | -100.38% |
| 2018-12-31 | ₩76.88 Billion ≈ $52.10 Million |
₩10.49 Billion ≈ $7.11 Million |
0.136x | -4.30% |
| 2017-12-31 | ₩76.75 Billion ≈ $52.02 Million |
₩10.94 Billion ≈ $7.42 Million |
0.143x | +7.31% |
| 2016-12-31 | ₩66.15 Billion ≈ $44.83 Million |
₩8.79 Billion ≈ $5.96 Million |
0.133x | +233.71% |
| 2015-12-31 | ₩61.06 Billion ≈ $41.38 Million |
₩2.43 Billion ≈ $1.65 Million |
0.040x | -62.31% |
| 2014-12-31 | ₩58.51 Billion ≈ $39.65 Million |
₩6.18 Billion ≈ $4.19 Million |
0.106x | -51.73% |
| 2013-12-31 | ₩62.03 Billion ≈ $42.04 Million |
₩13.57 Billion ≈ $9.20 Million |
0.219x | +132.79% |
| 2012-12-31 | ₩61.39 Billion ≈ $41.60 Million |
₩5.77 Billion ≈ $3.91 Million |
0.094x | +56.14% |
| 2011-12-31 | ₩56.99 Billion ≈ $38.62 Million |
₩3.43 Billion ≈ $2.32 Million |
0.060x | -- |
About DAE HWA Pharmaceutical Co. Ltd
DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea. The company offers drugs for anticancer, antibiotics, antifungal and skin ailment, antivirus, anti-allergosis, hemorrhoids, antidepressant, antiepileptic, psychotropic agent, anti respiratory, anti-inflammatory, analgesic, skeletal muscle relaxants, osteoporosis, anti-arthriti… Read more